Actively Recruiting
A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
Led by Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Updated on 2025-12-31
210
Participants Needed
1
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is being conducted to evaluate the efficacy, and safety of SHR-2017 Injection in Patients with Bone Metastases from Solid Tumors. To explore the reasonable dosage of SHR-2017 Injection for Bone Metastases from Solid Tumors
CONDITIONS
Official Title
A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able and willing to provide a written informed consent
- Male or female, 18 years of age or older
- Histologically or cytologically confirmed solid tumors
- At least 1 bone metastasis demonstrated by radiologic imaging or histopathology
- Eastern Cooperative Oncology Group performance status of 2 or less
- Life expectancy of at least 6 months as judged by investigators
- Adequate organ function at Screening
- Female subjects with a negative blood pregnancy test and not breastfeeding
You will not qualify if you...
- Pre-existing or related oral diseases or oral cavity conditions requiring surgery
- History of major joint trauma or surgery before first dose of study drug
- Prior radiotherapeutic drugs or bone radiotherapy before first study drug administration
- Cardiovascular diseases deemed unfit for study participation by investigator
- Resting tachycardia or resting bradycardia
- Pain mainly from causes unrelated to bone metastases
- Unable to perform pain assessment
- Symptomatic or treatment-requiring brain or central nervous system metastases
- Comorbid infectious disease
- Prior treatment with exogenous nerve growth factor or anti-nerve growth factor antibodies
- History of allergy to relevant drug ingredients or components
- Participation in other clinical trials within a certain period
- Any other factors deemed unsuitable by investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060
Actively Recruiting
Research Team
Q
Qian Zhao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here